Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

PHASE2RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Myasthenia GravisMyasthenia Gravis, MuSK
Interventions
DRUG

NMD670

Tablets taken twice a day for 21 days

DRUG

Placebo

Tablets taken twice a day for 21 days

Trial Locations (37)

2333

RECRUITING

Leiden Universitair Medisch Centrum (LUMC), Leiden

16132

RECRUITING

IRCCS Ospedale Policlinico San Martino, Genova

20133

RECRUITING

IRCCS Fondazione Istituto Neurologico Carlo Besta, Dipartimento di Ricerca e Sviluppo clinico, Milan

20701

RECRUITING

Centrum Medyczne Hope Clinic, Lublin

21127

RECRUITING

ASST Papa Giovanni XXIII (Azienda Ospedaliera Papa Giovanni XXIII), Bergamo

27599

RECRUITING

The University of North Carolina at Chapel Hill, Chapel Hill

30912

RECRUITING

Augusta University, Neuroscience Center, Augusta

33487

RECRUITING

SFM Clinical Research, LLC, Boca Raton

38120

RECRUITING

Semmes Murphey Clinic, Memphis

40139

RECRUITING

IRCCS Istituo delle Scienze neurologiche di Bologna, UOC Clinica neurologica Ospedale, Bologna

56126

RECRUITING

AOU Pisana, Pisa

65212

RECRUITING

NextGen Precision Health, Columbia

80045

RECRUITING

University of Colorado Neuromuscular Division, Aurora

80138

RECRUITING

Centro Sclerosi Multipla Napoli - AOU Vanvitelli, Napoli

92011

RECRUITING

Profound Research LLC, Carlsbad

92868

RECRUITING

University of California Irvine Medical Center, Irvine

97239

RECRUITING

University of Oregon, Portland

Florida

RECRUITING

"Neuromuscular Research Division , University of South Florida"

Unknown

RECRUITING

UZ Leuven, Leuven

RECRUITING

Aarhus University Hospital, Aarhus

RECRUITING

Rigshospitalet University of Copenhagen, Copenhagen

RECRUITING

Centre de référence des maladies neuromusculaires AOC-CHU de Bordeaux - Hôpital Pellegrin, Bordeaux

RECRUITING

Centre de Référence des Maladies Neuromusculaires et de la SLA, Marseille

RECRUITING

Centre Hospitalier Universitaire de Nantes - Hôtel Dieu Centre de Référence des Maladies Neuromusculaires Rares -, Nantes

RECRUITING

Unité de Recherche Clinique NeuroSciences, Nice

RECRUITING

JSC Curatio, Tbilisi

RECRUITING

LTD David Tatishvili Health Center, Tbilisi

RECRUITING

Ltd New Hospitals, Tbilisi

RECRUITING

DIMER, IRCCS, Ospedale San Raffaele, Milan

RECRUITING

Neurologia Śląska Centrum Medyczne, Katowice

RECRUITING

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie sp.z o.o, Krakow

RECRUITING

Galen Clinic, Lublin

RECRUITING

Centrum Medyczne Neuro Protect, Warsaw

RECRUITING

University Clinical Center of Serbia, Neurology Clinic, Belgrade

RECRUITING

University Clinical Center Nis, Neurology Clinic, Niš

RECRUITING

Hospìtal Universitari Vall d'Hebrón, Barcelona

00189

RECRUITING

Azienda Ospedaliera Sant'Andrea - Universita di Roma La Sapienza, Roma

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NMD Pharma A/S

INDUSTRY

NCT06414954 - Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis | Biotech Hunter | Biotech Hunter